Tibet AIM Pharm. Inc.

SZSE:002826 Stock Report

Market Cap: CN¥1.7b

Tibet AIM Pharm Balance Sheet Health

Financial Health criteria checks 6/6

Tibet AIM Pharm has a total shareholder equity of CN¥738.8M and total debt of CN¥8.3M, which brings its debt-to-equity ratio to 1.1%. Its total assets and total liabilities are CN¥953.5M and CN¥214.7M respectively. Tibet AIM Pharm's EBIT is CN¥61.2M making its interest coverage ratio -21.9. It has cash and short-term investments of CN¥387.9M.

Key information

1.1%

Debt to equity ratio

CN¥8.28m

Debt

Interest coverage ratio-21.9x
CashCN¥387.89m
EquityCN¥738.76m
Total liabilitiesCN¥214.72m
Total assetsCN¥953.48m

Recent financial health updates

No updates

Recent updates

Some Confidence Is Lacking In Tibet AIM Pharm. Inc.'s (SZSE:002826) P/E

Jun 07
Some Confidence Is Lacking In Tibet AIM Pharm. Inc.'s (SZSE:002826) P/E

Investors Can Find Comfort In Tibet AIM Pharm's (SZSE:002826) Earnings Quality

May 02
Investors Can Find Comfort In Tibet AIM Pharm's (SZSE:002826) Earnings Quality

Risks Still Elevated At These Prices As Tibet AIM Pharm. Inc. (SZSE:002826) Shares Dive 26%

Feb 29
Risks Still Elevated At These Prices As Tibet AIM Pharm. Inc. (SZSE:002826) Shares Dive 26%

Financial Position Analysis

Short Term Liabilities: 002826's short term assets (CN¥524.7M) exceed its short term liabilities (CN¥208.7M).

Long Term Liabilities: 002826's short term assets (CN¥524.7M) exceed its long term liabilities (CN¥6.0M).


Debt to Equity History and Analysis

Debt Level: 002826 has more cash than its total debt.

Reducing Debt: 002826's debt to equity ratio has reduced from 11.2% to 1.1% over the past 5 years.

Debt Coverage: 002826's debt is well covered by operating cash flow (2447%).

Interest Coverage: 002826 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies